There will be major changes in the global pharmaceutical market and key changes in the top ten company list by 2012, says a new report from
URCH Publishing, provider of
pharmaceutical industry business information.
The report, Pharmaceutical Market Trends, 2008 - 2012 -
Key market forecasts and growth opportunities, forecasts that
Pfizer will fall from first to third place in the coveted list. The list in 2012 will be headed by
GlaxoSmithKline (
GSK) followed by
Roche.
Pfizer was the leading company in 2007 with a market share of 6.2%.
GSK was in second position with a 5.4% market share and
Roche held a share of 4.3%.
The top ten companies, ranked by pharmaceutical
sales, generated total sales of $284 billion in 2007. “
Total pharmaceutical sales from these companies accounted for more than 40% of the total market,” said Steve Seget the report’s author. “However, only two of the top ten pharmaceutical corporations in 2007 are forecast to grow at a rate above the overall pharmaceutical market over the next five years; Roche with a CAGR of 6.2% and
Novartis with a CAGR of 6.1%,” he added.
The report also concludes that
Johnson & Johnson and
Merck will suffer stagnant growth in the four year period.
The global pharmaceutical market is forecast to grow to $929 billion in 2012, an equivalent CAGR of 5.5% over the next four years. The study says future sales growth will remain limited by high prescription drug co-pays for insured consumers, the growing availability of generic
drugs and a lack of new
blockbuster drugs to replace the leading products scheduled to lose
patent protection.
“Pharmaceutical Market Trends, 2008- 2012 - Key market forecasts and growth opportunities (3rd Edition)” is available from URCH Publishing.